BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) and Strides Pharma Science Limited (“Strides”) today announced the addition of Icosapent ethyl ...
HYDERABAD, India and Princeton, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr.
DUBLIN, Ireland and BRIDGEWATER, N.J., March 30, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), today announced that data presented by Deepak L. Bhatt ...
Amneal and Strides are set to introduce Icosapent ethyl acid soft gel capsules, which is the generic of Vascepa. The product has been in-licensed from Strides and will be commercialized by Amneal ...
Higher levels of the omega-3 fatty acid eicosapentaenoic acid (EPA) found in the blood appear to explain why icosapent ethyl drives down the risk of a cardiovascular (CV) event, according to findings ...
Daily icosapent ethyl (Vascepa) safely and effectively reduces fatal and nonfatal ischemic events in patients with reduced kidney function, a prespecified analysis of the REDUCE-IT RENAL study shows. ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — In patients with elevated triglycerides at high CV risk despite statin therapy, icosapent ethyl was ...
Amarin Corporation announced the presentation of new in vitro data on eicosapentaenoic acid (EPA) at the American College of Cardiology's Annual Scientific Session & Expo from March 29-31, 2025. The ...
Please provide your email address to receive an email when new articles are posted on . Improvements in CV outcomes from hypertriglyceridemia treatment with icosapent ethyl, compared with placebo, ...